Sanofi Agrees To Buy Dynavax At $15.50 Per Share Valuing Company At $2.2B And Representing 39% Premium, Expanding Presence In Adult Immunization And Vaccine Development

Benzinga · 12/24/2025 07:17

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price on December 23, 2025